↓ Skip to main content
What is this page? Embed badge

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

Overview of attention for article published in BMC Cancer, June 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
56 Mendeley
Summary X Dimensions citations
So far, Dimensions has found 23 publications that cite this research output.

23

The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.